Informação sobre produto
- (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-[(methoxy-d3)-methyl]-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
- M-23 Metabolite-d3
- (3R,5S,6E)- 7-[4-(4-Fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
- 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(2-hydroxy-1-methylethyl)-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, monosodium salt, [3R-[3R*,5S*,6E,7(S*)]]-
- 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)-
- M-23 Metabolite
- M-23 Metabolite, Sodium (E)-7-(3R,5S)-{4-(4-Fluorophenyl)-6-[(S)-(hydroxymethyl)ethyl]-2-isopropyl-5-methoxymethylpyrid-3-yl}-3,5-dihydroxyhept-6-enoate
- Sodium (E)-7-(3R,5S)-(4-(4-Fluorophenyl)-6-[(S)-(Hydroxymethyl)Ethyl]-2-Isopropyl-5-Methoxymethylpyrid-3-Yl)-3,5-Dihydroxyhept-6-Enoate
Applications A labelled metabolite of Cerivastatin, a competitive inhibitor of HMG-CoA reductase.
References Boberg, M., et al.: Drug Metab. Dispos., 25, 321 (1997),
Propriedades químicas
Consulta técnica sobre: TR-H900252 Hydroxy Cerivastatin-d3 Sodium Salt
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.